BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32120995)

  • 21. Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.
    Zheng ZZ; Xia L; Hu GS; Liu JY; Hu YH; Chen YJ; Peng JY; Zhang WJ; Liu W
    Nucleic Acids Res; 2022 Oct; 50(18):10230-10248. PubMed ID: 36124682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
    Madak-Erdogan Z; Katzenellenbogen BS
    Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting FOXM1-Mediated Gene Regulation through the Analysis of Genome-Wide FOXM1 Binding Sites in MCF-7, K562, SK-N-SH, GM12878 and ECC-1 Cell Lines.
    Kang K; Choi Y; Kim HH; Yoo KH; Yu S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32858881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.
    Helzer KT; Szatkowski Ozers M; Meyer MB; Benkusky NA; Solodin N; Reese RM; Warren CL; Pike JW; Alarid ET
    Mol Cell Biol; 2019 Feb; 39(3):. PubMed ID: 30455249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.
    Sanders DA; Ross-Innes CS; Beraldi D; Carroll JS; Balasubramanian S
    Genome Biol; 2013 Jan; 14(1):R6. PubMed ID: 23347430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins.
    Sun JM; Spencer VA; Li L; Yu Chen H; Yu J; Davie JR
    Exp Cell Res; 2005 Jan; 302(1):96-107. PubMed ID: 15541729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites.
    Yamaga R; Ikeda K; Horie-Inoue K; Ouchi Y; Suzuki Y; Inoue S
    Horm Cancer; 2013 Aug; 4(4):222-32. PubMed ID: 23526455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program.
    Yang F; Ma Q; Liu Z; Li W; Tan Y; Jin C; Ma W; Hu Y; Shen J; Ohgi KA; Telese F; Liu W; Rosenfeld MG
    Mol Cell; 2017 May; 66(3):321-331.e6. PubMed ID: 28475868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
    Franco HL; Nagari A; Malladi VS; Li W; Xi Y; Richardson D; Allton KL; Tanaka K; Li J; Murakami S; Keyomarsi K; Bedford MT; Shi X; Li W; Barton MC; Dent SYR; Kraus WL
    Genome Res; 2018 Feb; 28(2):159-170. PubMed ID: 29273624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.
    Holding AN; Giorgi FM; Donnelly A; Cullen AE; Nagarajan S; Selth LA; Markowetz F
    Genome Biol; 2019 May; 20(1):91. PubMed ID: 31084623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription.
    Nagarajan S; Hossan T; Alawi M; Najafova Z; Indenbirken D; Bedi U; Taipaleenmäki H; Ben-Batalla I; Scheller M; Loges S; Knapp S; Hesse E; Chiang CM; Grundhoff A; Johnsen SA
    Cell Rep; 2014 Jul; 8(2):460-9. PubMed ID: 25017071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.
    Grober OM; Mutarelli M; Giurato G; Ravo M; Cicatiello L; De Filippo MR; Ferraro L; Nassa G; Papa MF; Paris O; Tarallo R; Luo S; Schroth GP; Benes V; Weisz A
    BMC Genomics; 2011 Jan; 12():36. PubMed ID: 21235772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
    Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
    Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.
    Tong Z; Liu Y; Yu X; Martinez JD; Xu J
    J Biol Chem; 2019 Dec; 294(51):19667-19682. PubMed ID: 31744881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
    Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
    Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).
    Qi J; Huo L; Zhu YT; Zhu YJ
    J Biol Chem; 2014 Nov; 289(45):31373-81. PubMed ID: 25258321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation.
    Li W; Hu Y; Oh S; Ma Q; Merkurjev D; Song X; Zhou X; Liu Z; Tanasa B; He X; Chen AY; Ohgi K; Zhang J; Liu W; Rosenfeld MG
    Mol Cell; 2015 Jul; 59(2):188-202. PubMed ID: 26166704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation.
    Korkmaz G; Manber Z; Lopes R; Prekovic S; Schuurman K; Kim Y; Teunissen H; Flach K; Wit E; Galli GG; Zwart W; Elkon R; Agami R
    Nucleic Acids Res; 2019 Oct; 47(18):9557-9572. PubMed ID: 31372638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.